Bleeding diathesis: Difference between revisions
Line 213: | Line 213: | ||
| rowspan="5" |Qualitative Disorders of [[Platelet]] Function<span name="harr_c115s002s004s001p001"></span><span name="9100803"></span> | | rowspan="5" |Qualitative Disorders of [[Platelet]] Function<span name="harr_c115s002s004s001p001"></span><span name="9100803"></span> | ||
| rowspan="3" |Inherited Disorders of [[Platelet]] Function<span name="harr_c115s002s004s001p001"></span><span name="9100803"></span> | | rowspan="3" |Inherited Disorders of [[Platelet]] Function<span name="harr_c115s002s004s001p001"></span><span name="9100803"></span> | ||
|Glanzmann’s thrombasthenia | |[[Glanzmann's thrombasthenia|Glanzmann’s thrombasthenia]] | ||
| | | | ||
* Positive family history | |||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
Line 227: | Line 228: | ||
|AR inheritance/ absence of the platelet Gp IIb/IIIa receptor | |AR inheritance/ absence of the platelet Gp IIb/IIIa receptor | ||
|- | |- | ||
|Bernard-Soulier syndrome | |[[Bernard-Soulier syndrome]] | ||
| | | | ||
* Positive family history | |||
| | | | ||
| | | | ||
Line 241: | Line 243: | ||
|AR inheritance/ absence of the platelet Gp Ib-IX-V receptor | |AR inheritance/ absence of the platelet Gp Ib-IX-V receptor | ||
|- | |- | ||
|Platelet storage pool disorder (SPD) | |[[Platelet storage pool deficiency|Platelet storage pool disorder (SPD)]] | ||
| | | | ||
* Positive family history | |||
| | | | ||
| | | | ||
Line 255: | Line 258: | ||
|AD inheritance/ abnormalities of platelet granule formation | |AD inheritance/ abnormalities of platelet granule formation | ||
|- | |- | ||
|Acquired Disorders of [[Platelet]] Function<span name="harr_c115s002s004s002p001"></span><span name="9100808"></span> | | colspan="2" |Acquired Disorders of [[Platelet]] Function<span name="harr_c115s002s004s002p001"></span><span name="9100808"></span> | ||
| | | | ||
* [[Medication|Medications]] eg. high-dose [[Penicillin|penicillins]] | |||
* [[Chronic renal failure pathophysiology|Uremia]] | |||
* Cardiopulmonary bypass | |||
* Hematologic disorders such as: [[Myeloproliferative disease|myeloproliferative]] and [[Myelodysplastic syndrome|myelodysplastic syndromes]] | |||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
Line 270: | Line 276: | ||
| | | | ||
|- | |- | ||
|[[Von Willebrand disease|Von Willebrand Disease]]<span name="harr_c115s002s005p001"></span><span name="9100810"></span> | | colspan="2" |[[Von Willebrand disease|Von Willebrand Disease]]<span name="harr_c115s002s005p001"></span><span name="9100810"></span> | ||
| | | | ||
* Easy bruising | * Easy bruising | ||
Line 294: | Line 299: | ||
| colspan="2" |[[Metabolism|Metabolic]] and [[Inflammation|Inflammatory]] Disorders | | colspan="2" |[[Metabolism|Metabolic]] and [[Inflammation|Inflammatory]] Disorders | ||
| | | | ||
* Acute febrile illnesses | |||
* [[Cryoglobulinemia|Mixed cryoglobulinemia]] | |||
* [[Monoclonal gammopathy|Monoclonal gammopathies]] | |||
* Certain pathogens, such as the rickettsiae causing [[Rocky Mountain spotted fever]] | |||
* [[Vitamin C]] deficiency, | |||
* [[Cushing's syndrome|Cushing’s syndrome]], | |||
* Chronic [[glucocorticoid]] therapy, | |||
* [[Ageing|Aging]] (''senile purpura)'', | |||
* [[Vasculitis]] such as Henoch-Schönlein, | |||
| | | | ||
| | * History of the underlying disease. | ||
| | |<nowiki>+</nowiki> | ||
| | |<nowiki>+</nowiki> | ||
| | |<nowiki>+/-</nowiki> | ||
| | | - | ||
| - | |||
| | | | ||
| | | | ||
Line 309: | Line 324: | ||
| colspan="2" |Inherited Disorders of the [[Vessel wall|Vessel Wall]] | | colspan="2" |Inherited Disorders of the [[Vessel wall|Vessel Wall]] | ||
| | | | ||
* [[Marfan's syndrome|Marfan’s syndrome]] | |||
* [[Ehlers-Danlos syndrome]] | |||
* [[Pseudoxanthoma elasticum]] | |||
* [[Hereditary hemorrhagic telangiectasia]] ([[Hereditary hemorrhagic telangiectasia|HHT]], or [[Osler-Weber-Rendu|Osler-Weber-Rendu disease]]) | |||
| | | | ||
| | * Family history | ||
| | |<nowiki>+</nowiki> | ||
| | |<nowiki>+</nowiki> | ||
| | |<nowiki>+/-</nowiki> | ||
| | | - | ||
| - | |||
| | | | ||
| | | | ||
Line 323: | Line 343: | ||
|- | |- | ||
| rowspan="12" |Coagulation factor disorders | | rowspan="12" |Coagulation factor disorders | ||
| colspan=" | | colspan="3" |[[Fibrinogen]] deficiency | ||
| | | | ||
* [[Epistaxis]] | * [[Epistaxis]] | ||
Line 350: | Line 369: | ||
|The severity of bleeding in patients with fibrinogen disorders can be mild or severe, with higher bleeding risk in those with afibrinogenemia or lower levels of functional fibrinogen. The age of onset is also variable, with earlier onset in those with more severe deficiency. | |The severity of bleeding in patients with fibrinogen disorders can be mild or severe, with higher bleeding risk in those with afibrinogenemia or lower levels of functional fibrinogen. The age of onset is also variable, with earlier onset in those with more severe deficiency. | ||
|- | |- | ||
| colspan=" | | colspan="3" |[[Prothrombin deficiency]] | ||
| | | | ||
* Easy [[bruising]] | * Easy [[bruising]] | ||
Line 373: | Line 391: | ||
| | | | ||
|- | |- | ||
| colspan=" | | colspan="3" rowspan="1" |[[Factor V deficiency]] | ||
| | | | ||
* Excessive bruising with minor injuries | * Excessive bruising with minor injuries | ||
Line 394: | Line 411: | ||
|The severity of bleeding is only partly related to the degree of factor V deficiency. Some patients with undetectable plasma levels of factor V experience only relatively mild bleeding. | |The severity of bleeding is only partly related to the degree of factor V deficiency. Some patients with undetectable plasma levels of factor V experience only relatively mild bleeding. | ||
|- | |- | ||
| colspan=" | | colspan="3" rowspan="1" |[[Factor VII deficiency]] | ||
| | | | ||
* Easy [[Bruise|bruising]] | * Easy [[Bruise|bruising]] | ||
Line 415: | Line 431: | ||
|Thrombosis occurs in inherited factor VII deficiency most cases are associated with the administration of factor VII replacement therapy | |Thrombosis occurs in inherited factor VII deficiency most cases are associated with the administration of factor VII replacement therapy | ||
|- | |- | ||
| colspan=" | | colspan="3" rowspan="1" |[[Factor X deficiency]] | ||
| | | | ||
* Prolonged bleeding following circumcision | * Prolonged bleeding following circumcision | ||
Line 441: | Line 456: | ||
| | | | ||
|- | |- | ||
| colspan=" | | colspan="3" rowspan="1" |[[Factor XII|Factor XII deficiency]] | ||
| | | | ||
* Majority,asymptomatic | * Majority,asymptomatic |
Revision as of 17:01, 10 September 2018
Bleeding diathesis main page |
|
---|
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Mehrian Jafarizade, M.D [2], Nazia Fuad M.D.
Overview
Bleeding diathesis is unusual susceptibility to bleed due to hypo-coagulopathies. These diseases can occur due to a disorder of homeostasis, localized process (tissue injury), or medications. Bleeding diathesis can be resulted from vessel wall injury, platelet disorders, and coagulation factor disorders. Clinical manifestation of bleeding disorders can have a wide range of symptoms from asymptomatic to symptomatic massive and life threatening bleeding. Platelet disorders mostly have skin manifestations such as petechiae, and ecchymoses. In order to find the cause of hypo-coagulopathy; there are established laboratory tests, such as peripheral blood smear, platelet count and platelet function analysis, coagulation factor deficiencies and inhibitors, fibrinolysis tests (eg. D-dimer level), bleeding time, prothrombin time, activated partial thromboplastin time, thrombin time and reptilase time.
Homostasis
Hemostasis is the process of blood clot formation at the site of bleeding. This process has 4 main phases as below:
Platelet plug formation
Coagulation cascade
Antithrombotic control
Fibrinolysis
Classification
Disorders of hemostasis can be classified into two main categories: platelet disorders, and disorders of coagulation. Each category can be further classified as bellow:
Platelet disorders:
- Thrombocytopenia: platelet count less than 150,000 per mm3
- Thromobcytosis: platelet countcmore than 450,000 per mm3
- Qualitative Disorders of Platelet function such as Von Willebrand Disease, inherited or acquired functional disorders.
Coagulation disorders
- Vessel wall disorders: Endothelial cells are lining entire vessel walls all over the body. Endothelium is an active layer responsible for inflammatory responses, angiogenesis and blood cell interactions. Endothelial cells have a very important role in hemostasis and they are regulating blood fluidity by the balance of antithrombotic/prothrombotic and vasodilatory/vasoconstrictor effects.
- Metabolic and Inflammatory Disorders
- Inherited Disorders of the Vessel Wall
- Coagulation factor disorders:
- Fibrinogen deficiency
- Prothrombin deficiency
- Factor V deficiency
- Factor VII deficiency
- Factor X deficiency
- Factor XII deficiency
- HK deficiency
- Prekallikrein deficiency
- Factor XIII deficiency
- Hemophilia
- Disseminated Intravascular Coagulation
- Vitamin K Deficiency
- Coagulation Disorders Associated with Liver Failure
- Acquired Inhibitors of Coagulation Factors
Differential Diagnosis
Category | Sub-category | Diseases | History | Clinical manifestation | Laboratory testing | Comments | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Petechiae | Ecchymoses | Menorrhagia | Hematoma | Hemarthrosis | Platelet count | Bleeding time (BT) | Prothrombin time (PT) | Activated partial thromboplastin time (aPTT) | Thrombin time (TT) | ||||||
Platelet disorders | Thrombocytopenia | Infection-Induced Thrombocytopenia |
|
+ | + | + | + | + | ↓ | N | N | ||||
Medications-Induced Thrombocytopenia |
|
+ | + | + | + | + | ↓ | N | N | ||||||
Heparin-Induced Thrombocytopenia |
|
+ | + | + | + | + | ↓ | ||||||||
Immune Thrombocytopenic Purpura (ITP) |
|
+ | + | + | + | + | ↓ | ↑ | N | N | |||||
Inherited Thrombocytopenia |
|
+ | + | + | + | + | ↓ | ↑ | N | N | |||||
Thrombotic Thrombocytopenic Purpura (TTP) | History of:
|
+ | + | + | + | + | ↑ | ||||||||
Hemolytic Uremic Syndrome | History of:
|
+ | + | + | + | + | N | N | |||||||
Thromobcytosis |
|
− | − | − | + | + | ↑ | Normal or slightly prolonged | ɴ | ɴ | |||||
Qualitative Disorders of Platelet Function | Inherited Disorders of Platelet Function | Glanzmann’s thrombasthenia |
|
+ | + | + | + | + | AR inheritance/ absence of the platelet Gp IIb/IIIa receptor | ||||||
Bernard-Soulier syndrome |
|
AR inheritance/ absence of the platelet Gp Ib-IX-V receptor | |||||||||||||
Platelet storage pool disorder (SPD) |
|
AD inheritance/ abnormalities of platelet granule formation | |||||||||||||
Acquired Disorders of Platelet Function |
|
+ | + | + | + | + | |||||||||
Von Willebrand Disease |
|
+ | + | + | + | + | ↑ | Ν | ↑ | ↑ | |||||
Vessel wall disorders | Metabolic and Inflammatory Disorders |
|
|
+ | + | +/- | - | - | |||||||
Inherited Disorders of the Vessel Wall |
|
+ | + | +/- | - | - | |||||||||
Coagulation factor disorders | Fibrinogen deficiency |
|
_ | + | + | + | N | ↑ | ↑ | ↑ | ↑ | The severity of bleeding in patients with fibrinogen disorders can be mild or severe, with higher bleeding risk in those with afibrinogenemia or lower levels of functional fibrinogen. The age of onset is also variable, with earlier onset in those with more severe deficiency. | |||
Prothrombin deficiency |
|
+ | + | + | + | + | N | N | ↑ | ↑ | ↑ | ||||
Factor V deficiency |
|
_ | + | + | + | + | N | ↑ | ↑ | ↑ | N | The severity of bleeding is only partly related to the degree of factor V deficiency. Some patients with undetectable plasma levels of factor V experience only relatively mild bleeding. | |||
Factor VII deficiency |
|
+ | + | + | N | ↑ | N | Thrombosis occurs in inherited factor VII deficiency most cases are associated with the administration of factor VII replacement therapy | |||||||
Factor X deficiency |
|
+ | + | + | + | + | N | N | ↑ | ↑ | N | ||||
Factor XII deficiency |
|
_ | _ | _ | _ | _ | N | N | ↑ | ↑ | N | ||||
HK deficiency | |||||||||||||||
Prekallikrein deficiency | |||||||||||||||
Factor XIII deficiency | |||||||||||||||
Hemophilia | Type A deficiency |
|
_ | _ | + | + | + | Unaffected | Unaffected | Unaffected | Prolonged | N | |||
Type B deficiency |
|
_ | _ | + | + | + | Unaffected | N | N | ↑ | N | ||||
Type C deficiency |
|
_ | _ | + | Rare | Rare | N | N | N | ↑ | N | ||||
Rare diseases | Disseminated Intravascular Coagulation |
|
+ | + | _ | + | + | ↓ | ↑ | ↑ | ↑ | ||||
Vitamin K Deficiency |
|
+ | + | + | + | + | N | ↑ | ↑ | Normal or mildly prolonged | |||||
Coagulation Disorders Associated with Liver Failure | |||||||||||||||
Acquired Inhibitors of Coagulation Factors |
Type of VWD | Type of factor deficiency | Prevalence | Inheritance pattern | Clinical manifestations | VWF activity | RIPA | Factor VIII | Plt levels | ||
---|---|---|---|---|---|---|---|---|---|---|
Type 1 | Quantitative/ partial | |||||||||
Type 2 | 2A | |||||||||
2B | ||||||||||
2M | ||||||||||
2N | ||||||||||
Type 3 |